Skip to main content

Free Content Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997–98

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Objective To assess the susceptibility of the key respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.

Methods Isolates were collected from five centers in Brazil during 1997–98, and susceptibility testing was conducted at a central laboratory according to National Committee for Clinical Laboratory Standards criteria.

Results Of the 359Streptococcus pneumoniae isolates tested, 77% were susceptible, 19% were intermediate and 4% were resistant to penicillin. The susceptibility of S. pneumoniae to other -lactams and macrolides was greater than 90%, but cotrimoxazole was active against only 48% of the isolates. The prevalence of susceptible isolates was 100.0% for vancomycin and 99.7% for levofloxacin. -Lactam, macrolide, and cotrimoxazole activities were negatively associated with penicillin resistance. Of the 219 isolates of Haemophilus influenzae tested, 11% produced -lactamase and 11% were not susceptible to ampicillin. Nearly all H. influenzae isolates were susceptible to all other drugs, except cotrimoxazole (47% susceptibility). Of the 52 Moraxella catarrhalis isolates, 98% produced -lactamase, and the MIC of all drugs was 4 mg/L, with the exception of ampicillin, where the MIC90 was> 8 mg/L.

Conclusions When these data are compared with previous reports, our findings suggest that the prevalence of pneumococci that are resistant to agents such as penicillin and cotrimoxazole may be increasing in Brazil, which highlights the need to continue surveillance programs.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Streptococcus pneumoniae; antibiotic resistance; surveillance

Document Type: Research Article

Affiliations: 1: MRL Pharmaceutical Services, Herndon, VA, USA, 2: MRL Pharmaceutical Services, Brentwood, TN, USA, 3: MRL Pharmaceutical Services, Utrecht, The Netherlands, 4: Hospital de Clinicas de Porto Alegre, Porto Alegre, 5: Laboratorio Fleury, Hospital das Clinicas Sao Paulo, Sao Paulo, 6: Hospital A.C. Carmargo, Camargo, 7: Federal University of Sao Paulo, Sao Paulo, and 8: Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Publication date: 01 April 2000

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more